Skip to content

The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis

The Strength Training and Remicade Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00327275
Enrollment
35
Registered
2006-05-18
Start date
2004-03-31
Completion date
2005-01-31
Last updated
2006-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

To assess the effects of a 16-week individualized, intensive strength training program in patients with rheumatoid arthritis. Primary and secondary outcomes include: strength and body composition, function, disease activity, pain, quality of life. We hypothesized that improvements would be seen in all of the above outcomes.

Interventions

BEHAVIORALstrength training

Sponsors

Centocor, Inc.
CollaboratorINDUSTRY
University of Arizona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Males and females with RA * Over 18 years of age * ACR Functional Class I and II * Taking Remicade \>4 months

Exclusion criteria

* Presence of comorbid conditions contraindicated to exercise, including, but not limited to: 1. heart disease 2. severe osteoporosis: (if \>50 years): T score \< -3.0 for hip or spine excluded; T score \<-2.5 for hip or spine w/o current treatment) 3. (all potential subjects) previous non-traumatic fractures 4. uncontrolled BP * BMI \>40 * Regular use of assistive walking device which would interfere with ability to lift weights * Currently or within the last 3 months participating in aerobic exercise \> 150 minutes a week * Currently or within the last 3 months participating in any regular strength training activities * Presence of neurological impairment that directly limits ability to perform exercise * Participation in concurrent exercise study * Any reason for which the investigator deems it would not be in the patient's best interest to continue in the study * Plans to move away from site within next 1 year

Design outcomes

Primary

MeasureTime frame
Strength
Body Composition
Function
Pain

Secondary

MeasureTime frame
Disease Activity
Fatigue
Quality of Life

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026